Catalyst

Slingshot members are tracking this event:

Blueprint Medicines' (BPMC) to Present Avapritinib in Advanced Systemic mastocytosis (SM) Phase 2 Data at AACR April 11, 2021 from 2pm ET

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BPMC Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Advanced Systemic Mastocytosis, Avapritinib, Aacr